MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
Cardiovascular diseases, involving vasculopathy, cardiac dysfunction, or circulatory disturbance, have become the major cause of death globally and brought heavy social burdens. The complexity and diversity of the pathogenic factors add difficulties to diagnosis and treatment, as well as lead to poo...
Main Authors: | Meng-Wan Zhang, Yun-Jie Shen, Jing Shi, Jian-Guang Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.610561/full |
Similar Items
-
miR-223: A Key Regulator in the Innate Immune Response in Asthma and COPD
by: Mirjam P. Roffel, et al.
Published: (2020-05-01) -
The Potential Therapeutic Role of miR-223 in Bovine Endometritis by Targeting the NLRP3 Inflammasome
by: Gan Zhao, et al.
Published: (2018-08-01) -
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
by: Xiaolan Zhu, et al.
Published: (2019-02-01) -
miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma
by: Zhang Hong-Tao, et al.
Published: (2011-03-01) -
The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
by: Zhang YF, et al.
Published: (2017-06-01)